AVE 20.0% 0.3¢ avecho biotechnology limited

orbis investments

  1. 10,009 Posts.
    have seen two good articles this week regarding Orbis investment strategy in BIOs. And the strong success they have had. Saturdays FIN review and this weeks Bioshares both gave ORBIS a big wrap.

    The take up just under 20 % of stock and hold for the longer ride. POH is the only one of about 8 that hasn't performed share price wise yet.

    But they certainly know how the pick the quality shares, with ACR, SPL,IMP,ACL, in their portfolio.

    Stick with the winners. We are in good company here.

    poS
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $2.75K 916.6K

Buyers (Bids)

No. Vol. Price($)
49 88052619 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 59580557 20
View Market Depth
Last trade - 10.00am 19/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.